Compugen CGEN
NASDAQ CGEN
$2.59 +0.03 (+1.17%)
As of: Sep 4, 2026 · 3:19 PM EDT

Compugen (CGEN) Non-Current Deferred Tax Liability (2010 - 2015)

Compugen (CGEN) posted quarterly Non-Current Deferred Tax Liability of $105000.0 for Q3 2015, down 80.04% year-over-year from $526000.0 in Q3 2014, and down 50.0% on a QoQ basis from $210000.0 in Q2 2015.

Analysis

Compugen (CGEN) Non-Current Deferred Tax Liability (2010 - 2015) Analysis & Trends

Compugen has reported Non-Current Deferred Tax Liability for 6 years, with the latest figure at $105000.0 in Q3 2015.

  • Non-Current Deferred Tax Liability for Q3 2015 came in at $105000.0, down 80.04% year-over-year; the trailing twelve-month figure through Sep 2015 was $105000.0 (down 80.04% YoY), and the FY2014 annual result was $421000.0, down 96.81% from the prior year.
  • Non-Current Deferred Tax Liability eased to $105000.0 in Q3 2015, from $210000.0 in the prior quarter.
  • Over five years, Non-Current Deferred Tax Liability peaked at $14.2 million in Q1 2014 and troughed at $105000.0 in Q3 2015.
  • A 5-year average of $5.8 million and a median of $4.8 million in 2012 frame the typical range for Non-Current Deferred Tax Liability.
  • The widest annual swing landed in 2013, when Non-Current Deferred Tax Liability soared 142.68%; it then plunged 98.39% in 2015.
  • A 5-year view of Non-Current Deferred Tax Liability shows it stood at $6.1 million in 2011, then grew by 28.0% to $7.9 million in 2012, then soared by 67.54% to $13.2 million in 2013, then sank by 96.81% to $421000.0 in 2014, then plunged by 75.06% to $105000.0 in 2015.
  • Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $105000.0 in Q3 2015, $210000.0 in Q2 2015, and $316000.0 in Q1 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn
5 Revolution Medicines 43.98 Bn 43.98 Bn -
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn -
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn
10 Compugen 241.50 Mn 155.89 Mn -92,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2015 105,000.00
Jun 30, 2015 210,000.00
Mar 31, 2015 316,000.00
Dec 31, 2014 421,000.00
Sep 30, 2014 526,000.00
Jun 30, 2014 13.07 Mn
Mar 31, 2014 14.15 Mn
Dec 31, 2013 13.19 Mn
Sep 30, 2013 14.10 Mn
Dec 31, 2012 7.87 Mn
Sep 30, 2012 5.81 Mn
Jun 30, 2012 4.79 Mn
Mar 31, 2012 7.38 Mn
Dec 31, 2011 6.43 Mn
Sep 30, 2011 3.24 Mn
Jun 30, 2011 3.30 Mn
Mar 31, 2011 4.21 Mn
Dec 31, 2010 4.04 Mn